These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1455001

  • 1. [Late results and prognosis in glomerulonephritis. II. Prognosis in specific forms of glomerulopathies].
    Hruby Z.
    Przegl Lek; 1992; 49(1-2):28-30. PubMed ID: 1455001
    [No Abstract] [Full Text] [Related]

  • 2. [Late results and prognosis in glomerulonephritis. I. General remarks].
    Hruby Z.
    Przegl Lek; 1992; 49(1-2):26-7. PubMed ID: 1455000
    [No Abstract] [Full Text] [Related]

  • 3. [The immunosuppressive therapy of chronic (Bright's) nephritis].
    Krasnova TN, Shilov EM.
    Ter Arkh; 1993; 65(6):88-93. PubMed ID: 8378860
    [No Abstract] [Full Text] [Related]

  • 4. [Possibility of predicting the development of morphologic types of chronic glomerulonephritis based on clinico-functional data].
    Ratner MIa, Serov VV, Stenina II, Varshavskiĭ VA, Rozenfel'd BI.
    Klin Med (Mosk); 1988 Oct; 66(10):119-25. PubMed ID: 3236770
    [No Abstract] [Full Text] [Related]

  • 5. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 6. Steroid therapy in primary glomerulonephritis.
    Davison AM.
    Nephrol Dial Transplant; 1990 Feb; 5 Suppl 1():23-8. PubMed ID: 2129454
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The rarity of minimal change disease in Nigerian patients with the nephrotic syndrome.
    Kadiri S, Osobamiro O, Ogunniyi J.
    Afr J Med Med Sci; 1993 Dec; 22(4):29-34. PubMed ID: 7839926
    [Abstract] [Full Text] [Related]

  • 10. Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome.
    Dong JH, Xu ST, Xu F, Zhou YC, Li Z, Li SJ.
    Clin Exp Nephrol; 2021 Mar; 25(3):270-278. PubMed ID: 33398597
    [Abstract] [Full Text] [Related]

  • 11. [Intravenous immunoglobulins in the treatment of glomerulopathies].
    Floccari F, Palla R, Polito P, Campo S, Aloisi C, Buemi M.
    G Ital Nefrol; 2007 Mar; 24(4):311-9. PubMed ID: 17659502
    [Abstract] [Full Text] [Related]

  • 12. [Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Mar; 46(10):744-9. PubMed ID: 2687950
    [No Abstract] [Full Text] [Related]

  • 13. Glomerular disease made easier: 2.
    Robertson S, Isles C, More I.
    Br J Hosp Med; 1989 Mar; 53(7):323-6. PubMed ID: 7788069
    [No Abstract] [Full Text] [Related]

  • 14. [Histological classification of chronic glomerular diseases].
    Noël LH, Gubler MC.
    Rev Prat; 2003 Nov 30; 53(18):2005-12. PubMed ID: 15008214
    [Abstract] [Full Text] [Related]

  • 15. Pefloxacin as first-line treatment in nephrotic syndrome.
    Ginsburg C, Toledano D, Deray G, Vlassopoulos D, Baumelou A, Jacobs C.
    Nephrol Dial Transplant; 1994 Nov 30; 9(3):335. PubMed ID: 8052452
    [No Abstract] [Full Text] [Related]

  • 16. [Nephrotic syndrome].
    Sugiyama H, Makino H.
    Nihon Rinsho; 2005 May 30; 63 Suppl 5():521-5. PubMed ID: 15954403
    [No Abstract] [Full Text] [Related]

  • 17. Clinical outcomes and predictors for ESRD and mortality in primary GN.
    Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, Chiang WC, Lin SL, Tsai TJ, Wu KD, Chen YM.
    Clin J Am Soc Nephrol; 2012 Sep 30; 7(9):1401-8. PubMed ID: 22798538
    [Abstract] [Full Text] [Related]

  • 18. [Primary and secondary glomerular diseases].
    Birck R, Banas B.
    Dtsch Med Wochenschr; 2011 Apr 30; 136(14):703-5. PubMed ID: 21448831
    [No Abstract] [Full Text] [Related]

  • 19. Nephrotic Syndrome After Hematopoietic Stem Cell Transplant: Outcomes in Iran.
    Saddadi F, Alidadi A, Hakemi M, Bahar B.
    Exp Clin Transplant; 2017 Feb 30; 15(Suppl 1):90-92. PubMed ID: 28260442
    [Abstract] [Full Text] [Related]

  • 20. [Minimal-change glomerulonephritis and focal-segmental glomerulosclerosis-hyalinosis in adults].
    Diadyk AI, Khomenko MV, Shpilevaia NI, Iarovaia NF, Malovichko IS.
    Lik Sprava; 1996 Feb 30; (5-6):32-6. PubMed ID: 9377396
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.